Minerva notes continuous improvement in negative symptoms for users of roluperidone over one year in its Phase 3 trial...

https://www.thestar.com/business/thestreet/2021/05/12/minerva-shares-soar-on-positive-schizophrenia-drug-trial.html

#thestar